A Long-term Follow-up Study of Patients Who Received MB-105
ConditionAny Patient Treated With MB-105
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMarch Biosciences Inc
About this trial
This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- MB-105
Treatment groups
40 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov